Key Details
Annual Revenue
$325.00 KAnnual EPS
-$1.53Annual ROE
-119.60%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Feb 14, 2023Recent annual earnings:
Sept 23, 2021Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
No data about analysts updates
Screeners with AGTC included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Applied Genetic Technologies doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
FAQ
- What is the primary business of Applied Genetic Technologies?
- What is the ticker symbol for Applied Genetic Technologies?
- Does Applied Genetic Technologies pay dividends?
- What sector is Applied Genetic Technologies in?
- What industry is Applied Genetic Technologies in?
- What country is Applied Genetic Technologies based in?
- When did Applied Genetic Technologies go public?
- Is Applied Genetic Technologies in the S&P 500?
- Is Applied Genetic Technologies in the NASDAQ 100?
- Is Applied Genetic Technologies in the Dow Jones?
- When was Applied Genetic Technologies's last earnings report?
- When does Applied Genetic Technologies report earnings?
What is the primary business of Applied Genetic Technologies?
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing an optogenetic product candidate to treat advanced retinal disease. In addition, the company has initiated one preclinical program in otology; and two preclinical programs in targeting central nervous system disorders, including frontotemporal dementia and amyotrophic lateral sclerosis. It has collaboration agreements with University of Florida; Bionic Sight, LLC; and Otonomy, Inc. Applied Genetic Technologies Corporation was incorporated in 1999 and is headquartered in Alachua, Florida.
What is the ticker symbol for Applied Genetic Technologies?
The ticker symbol for Applied Genetic Technologies is NASDAQ:AGTC
Does Applied Genetic Technologies pay dividends?
No, Applied Genetic Technologies does not pay dividends
What sector is Applied Genetic Technologies in?
Applied Genetic Technologies is in the Healthcare sector
What industry is Applied Genetic Technologies in?
Applied Genetic Technologies is in the Biotechnology industry
What country is Applied Genetic Technologies based in?
Applied Genetic Technologies is headquartered in United States
When did Applied Genetic Technologies go public?
Applied Genetic Technologies's initial public offering (IPO) was on 27 March 2014
Is Applied Genetic Technologies in the S&P 500?
No, Applied Genetic Technologies is not included in the S&P 500 index
Is Applied Genetic Technologies in the NASDAQ 100?
No, Applied Genetic Technologies is not included in the NASDAQ 100 index
Is Applied Genetic Technologies in the Dow Jones?
No, Applied Genetic Technologies is not included in the Dow Jones index
When was Applied Genetic Technologies's last earnings report?
Applied Genetic Technologies's most recent earnings report was on 14 February 2023
When does Applied Genetic Technologies report earnings?
The date for Applied Genetic Technologies's next earnings report has not been announced yet